
CASI Pharmaceuticals
North America, Maryland, United States, Rockville
Description
CASI focus on building a pipeline through mutually beneficial business development transactions.
Investor Profile
CASI Pharmaceuticals has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in China.
- Strong thematic focus on Health Care, Biotechnology, Pharmaceutical.
Stage Focus
- Series A (50%)
- Series Unknown (50%)
Country Focus
- China (100%)
Industry Focus
- Health Care
- Biotechnology
- Pharmaceutical
- Medical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.